Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00386022Phase 3Unknown
Phase 3, open-label trial of estradiol topical in postmenopause (2 arms), sponsored by Massachusetts General Hospital. Primary endpoints: Pituitary Response to GnRH and Effect of Estrogen on Pituitary Response to GnRH. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00386022.